Publication Cover
Inhalation Toxicology
International Forum for Respiratory Research
Volume 27, 2015 - Issue 5
127
Views
3
CrossRef citations to date
0
Altmetric
Research Article

The beryllium bronchoalveolar lavage lymphocyte proliferation test: indicator of beryllium sensitization, inflammation or both?

&
Pages 262-271 | Received 04 Dec 2014, Accepted 03 Apr 2015, Published online: 05 May 2015

References

  • ACGIH (American Conference of Governmental Industrial Hygienists). (2002). Biological exposure index feasibility assessment for beryllium and inorganic compounds. Cincinnati, OH: ACGIH
  • Arjomandi M, Seward J, Gotway MB, et al. (2012). Low prevalence of chronic beryllium disease among workers at a nuclear Weapons Research and Development facility. J Occup Environ Med 52:647–52
  • ATSDR (Agency for Toxic Substances and Disease Registry). (2002). Toxicological profile for beryllium (PB2003-100135). Atlanta, GA: US Department of Health and Human Services, Public Health Service
  • Barna BP, Culver DA, Yen-Lieberman B, Dweik RA. (2003). Clinical application of beryllium lymphocyte proliferation testing. Clin Diagn Lab Immunol 10:990–4
  • Bobka CA, Stewart LA, Engelken GJ, et al. (1997). Comparison of in vivo and in vitro measures of beryllium sensitization. J Occup Environ Med 39:540–7
  • Cher DJ, Deubner DC, Kelsh MA, et al. (2006). Assessment of the beryllium lymphocyte proliferation test using statistical process control. Inhal Toxicol 18:901–10
  • Curtis GH. (1951). Cutaneous hypersensitivity due to beryllium: a study of thirteen cases. AMA Arch Derm Syphilol 64:470–82
  • Curtis GH. (1959). The diagnosis of beryllium disease, with special reference to the patch test. AMA Arch Ind Health 19:150–3
  • Deubner DC, Goodman M, Iannuzzi J. (2001). Variability, predictive value, and uses for the blood lymphocyte proliferation test (BeBLPT): preliminary analysis of the ongoing workforce survey. Appl Occup Environ Hyg 16:521–6
  • Donovan EP, Kolanz ME, Galbraith DA, et al. (2007). Performance of the beryllium blood lymphocyte proliferation test based on a long-term occupational surveillance program. Int Arch Occup Med Environ Health 81:165–78
  • Epstein PE, Dauber JH, Rossman MD, Danielle RP. (1982). Bronchoalveolar lavage in a patient with chronic berylliosis: evidence for hypersensitivity pneumonitis. Ann Intern Med 97:213–16
  • Fontenot AP, Maier LA, Canavera SJ, et al. (2002). Beryllium skin patch testing to analyze T cell stimulation and granulomatous inflammation of the lung. J Immunol 168:3627–34
  • Henneberger PK, Cumro D, Deubner DC, et al. (2001). Beryllium sensitization and disease among long-term and short-term workers in a beryllium ceramics plant. Int Arch Occup Environ Health 74:167–76
  • Kolanz ME. (2001). Introduction to beryllium: uses, regulatory history, and disease. Appl Occup Environ Hyg 16:559–67
  • Kreiss K, Mroz MM, Newman LS, et al. (1996). Machining risk of beryllium disease and sensitization with median exposures below 2 mg/m3. Am J Ind Med 30:16–25
  • Kreiss K, Mroz MM, Zhen B, et al. (1997). Risks of beryllium disease related to work processes at a metal, alloy, and oxide production plant. Occup Environ Med 54:605–12
  • Rossman MD, Kern JA, Elias JA, et al. (1988). Proliferate response of bronchoalveolar lymphocytes to beryllium: a test for chronic beryllium disease. Ann Intern Med 108:678–93
  • Rothman KR, Greenland S, Lash TL. (2008). Validity in epidemiologic studies. In: Rothman KR, Greenland A, Lash TL. (eds.) Modern epidemiology. 3rd Ed. Philadelphia: Lippincott Williams and Wilkins, 135–6
  • Schuler CR, Kent MS, Deubner DC, et al. (2005). Process-related risk of beryllium sensitization and disease in a copper-beryllium alloy facility. Am J Ind Med 47:195–205
  • Schuler CR, Virji MA, Deubner DC, et al. (2012). Sensitization and chronic beryllium disease at a primary manufacturing facility, part 3: exposure response in short-term workers. Scand J Work Environ Health 38:270–81
  • Stanton ML, Henneberger PK, Kent MS, et al. (2006). Sensitization and chronic beryllium disease among workers in copper-beryllium distribution centers. J Occup Environ Med 48:204–11
  • Virji MA, Park JY, Stefaniak AB, et al. (2012). Sensitization and chronic beryllium disease at a primary manufacturing facility, part 1: historical exposure reconstruction. Scand J Work Environ Health 38:247–58
  • Waksman BH. (1959). The diagnosis of chronic beryllium disease, with special reference to the patch test. AMA Arch Ind Health 19:154–6
  • Yoshida T, Shima S, Nagaoka K, et al. (1997). A study of the beryllium lymphocyte transformation test and the beryllium levels in working environment. Ind Health 35:374–9

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.